Moshe Fleshner-Barak

Title: Moshe Fleshner-Barak: Innovator in Pharmaceutical Composition

Introduction

Moshe Fleshner-Barak is a notable inventor based in Petach Tikva, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents to his name, his work focuses on enhancing the effectiveness of therapeutic agents.

Latest Patents

Fleshner-Barak's latest patents include a rapidly expanding composition for gastric retention and controlled release of therapeutic agents. This invention provides a pharmaceutical composition designed for oral administration, which expands upon contact with gastric fluid. It promotes the retention of the dosage form in the patient's stomach for an extended period, making it particularly useful in treating conditions such as Parkinson's disease and attention deficit disorder. Another notable patent involves a solid dosage form that features a core tablet sheathed in a compressed annular body of powder or granular material. This design minimizes contact between the active ingredient and the gastrointestinal tract lining, which is beneficial for delivering ulcerative drugs.

Career Highlights

Fleshner-Barak is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions that improve patient outcomes through advanced drug delivery systems.

Collaborations

Throughout his career, Fleshner-Barak has collaborated with esteemed colleagues such as E Itzhak Lerner and Vered Rosenberger. These partnerships have contributed to the development of groundbreaking pharmaceutical technologies.

Conclusion

Moshe Fleshner-Barak's contributions to the pharmaceutical industry exemplify the impact of innovation in drug delivery systems. His patents reflect a commitment to improving therapeutic efficacy and patient care.